首页> 外文期刊>Conference Papers in Science >“Quo Vadis” Oncologic Hyperthermia?
【24h】

“Quo Vadis” Oncologic Hyperthermia?

机译:“ Qu Vadis”肿瘤热疗?

获取原文
           

摘要

Hyperthermia was the very first oncotherapy in human medicine based directly on sacral and philosophical roots in ancient cultures. The discovery of electromagnetism gave new hopes a century ago; however, up to now it has been suffering from lack of wide applications. Oncological hyperthermia struggles with multiple technical and medical problems which are far from the complete solution. Technically, the deep heating, the precise focusing, the technical control, and repeatability are challenging. The missing medical explanation of the phenomenon, together with the he missing measurable dose hinders the acceptance of hyperthermia. The contra-feedback of physiology mechanisms makes this method hardly controllable. Multiple, most promising results and studies are mixed together with some negatives and controversial consequences, causing huge fluctuations of its applications. There are positive and negative “believers” of the method, but the decisional facts are missing. A new way gives shape to the development: heating in nanorange, which could solve most of the open problems in oncological hyperthermia.
机译:热疗是人类医学中第一个直接基于古代文化中部和哲学根源的肿瘤疗法。电磁学的发现给一个世纪前带来了新的希望。然而,到目前为止,它一直缺乏广泛的应用。肿瘤热疗难以解决多种技术和医学问题,而这些问题远非完整的解决方案。从技术上讲,深度加热,精确聚焦,技术控制和可重复性具有挑战性。缺少对该现象的医学解释,以及缺少可测量的剂量,都阻碍了对热疗的接受。生理机制的对立反馈使这种方法难以控制。多个,最有希望的结果和研究混杂在一起,同时也带来一些负面和有争议的后果,从而导致其应用发生巨大波动。该方法有正面和负面的“信徒”,但缺少决策事实。一种新的发展方式得以实现:纳米范围的加热,可以解决肿瘤学高温疗法中的大多数开放性问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号